Oxford Asset Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,214
| Closed | -$25K | – | 1809 |
|
|
2017
Q3 | $25K | Sell |
4,214
-64,566
| -94% | -$383K | ﹤0.01% | 1501 |
|
|
2017
Q2 | $576K | Buy |
+68,780
| New | +$576K | 0.01% | 1063 |
|
|
2015
Q3 | – | Sell |
-1,017
| Closed | -$20K | – | 703 |
|
|
2015
Q2 | $20K | Buy |
+1,017
| New | +$20K | ﹤0.01% | 647 |
|
|
2015
Q1 | – | Sell |
-8,608
| Closed | -$162K | – | 722 |
|
|
2014
Q4 | $162K | Buy |
+8,608
| New | +$162K | ﹤0.01% | 632 |
|